Mitch Conner
Santa Barbara, CA (USA)
Role(s):
Founder/Owner/Principal
EMCentrex
Find More Startups
Startup
Location:
Santa Barbara
Industry:
Bio-Technology
Year Founded:
2001
Number Employees:
1-10 people
Description:
Medical Device – Biotechnology – Antiviral, Anti-inflammatory, and Anti-cancer Markets
EMCentrex Executive Overview
EMCentrex Corporation has developed an advanced high powered magnetic impulse biotechnology that interferes with and neutralizes chronic viruses, inflammation, and cancer processes. EMCentrex has received one of the highest grant scores possible from the NIH. The company has leading virologists and biophysicists from UC Irvine and Columbia University on its team. The company also has an experienced biotech management team with successful biotechnology company and venture capital backgrounds. The antiviral and anti-inflammatory markets represent well-known and huge multi-billion dollar segments which speak for themselves. EMCentrex has conducted successful NIH / UC Irvine chronic virus animal testing with results confirming the biotechnology. The antiviral and anti-inflammatory markets represent well-known and huge multi-billion dollar segments that are greatly underserved in terms of addressing critical diseases and distressed people. We will have a tremendous humanitarian impact in terms of addressing critical afflictions such as AIDS/HIV; also Parkinson's Disease, Alzheimer's Disease, MS, and other neurological degenerative and inflammatory diseases; additionally Cancer and it's related tumor angiogenesis processes. Our biotechnology represents the Rosetta stone (RNA Interference) of the biotechnology industry similar to how Microsoft has been to the computer and Internet industries. Likewise, the new jobs created by our biotechnology will be analogous to the new job markets that were created by Microsoft’s entry into the computer field which had a global impact and changed the world forever for the better.